Ignite Creation Date:
2025-12-24 @ 11:40 PM
Ignite Modification Date:
2026-02-20 @ 10:46 PM
Study NCT ID:
NCT02383251
Status:
COMPLETED
Last Update Posted:
2023-09-06
First Post:
2015-03-04
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Paclitaxel/Pazopanib for Platinum Resistant/Refractory Ovarian Cancer
Sponsor:
ARCAGY/ GINECO GROUP
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
GINECO-OV231
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |